Survivors of high-risk neuroblastoma treated with modern therapies demonstrated a substantial burden of late effects, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback